COMMUNIQUÉS West-GlobeNewswire

Vereco Acquires CynergisTek’s Managed Print Services Business
21/03/2019
Acquisition solidifies Vereco’s status as leading independent provider of healthcare document services LAGUNA NIGUEL, Calif., March 21, 2019 (GLOBE NEWSWIRE) -- Vereco, LLC today announced an asset acquisition of [...]
Evolus Announces Publication of U.S. Phase III Pivotal Trial Results for Jeuveau™ in Dermatologic Surgery
21/03/2019
First Peer-Reviewed Publication from TRANSPARENCY Global Clinical Program Further Validates Safety and Efficacy of Jeuveau™ vs Placebo NEWPORT BEACH, Calif., March 21, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS [...]
OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial
21/03/2019
OPKO Health’s Oxyntomodulin, OPK88003, Shows Significant Reduction in HbA1c and Body Weight in Patients with Type 2 Diabetes MIAMI, March 21, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced [...]
Aleafia Health & Emblem Merger Creates a New Cannabis Leader -- CFN Media
21/03/2019
SEATTLE, March 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an [...]
VitalHub Introduces Patient Care Management and Flow Reviews
21/03/2019
TORONTO, March 21, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce that with its recent acquisition of the Oak Group Inc. (“Oak Group”), it will be introducing [...]
Aptinyx Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline and Business Progress
21/03/2019
Completed Phase 2 study of NYX-2925 in painful DPN -- did not meet primary endpoint, but NYX-2925 demonstrated robust analgesic activity in a large and mechanistically relevant patient sub-group Reported positive data [...]
Myriad to Present 18 Studies at the 2019 Annual Clinical Genetics Meeting
21/03/2019
SALT LAKE CITY, March 21, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in personalized medicine, today announced that its Myriad Women’s Health business unit will present data from 18 studies [...]
CureVac Announces Late-Breaking Poster Presentation at American Association of Cancer Research (AACR) Annual Meeting 2019
21/03/2019
TÜBINGEN, Germany and BOSTON, March 21, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, announced it will present interim data from its Phase I [...]
Unum Therapeutics to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast on March 28, 2019 at 8:00 A.M. ET
21/03/2019
CAMBRIDGE, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (Nasdaq: UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies to treat cancer using its [...]
Akorn Names Erislandy (Dandy) Dorado-Boladeres as Executive Vice President of Global Quality
21/03/2019
LAKE FOREST, Ill., March 21, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (NASDAQ: AKRX), today announced that Dandy Dorado-Boladeres has been named as Executive Vice President of Global Quality, effective March 25, 2019. Mr. [...]
Algernon Pharmaceuticals Appoints Leading Liver Disease Expert Dr. Arun Sanyal to Its Medical and Scientific Advisory Board
21/03/2019
VANCOUVER, British Columbia, March 21, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development [...]
ContraFect to Present at the Bacteriophage Therapy Summit
21/03/2019
YONKERS, N.Y., March 21, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of novel, differentiated biologic therapeutics for [...]
Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimer’s Disease
21/03/2019
Independent data monitoring committee advises aducanumab unlikely to meet primary endpoints, leading to decision to discontinue the trials CAMBRIDGE, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) and [...]
Teleflex Announces Real-World Data Demonstrating the Effectiveness of the UroLift® System to Treat Patients with Enlarged Prostate
21/03/2019
Findings Presented at European Association of Urology Show Consistent Positive Results for Minimally Invasive UroLift System Treatment WAYNE, Pa., March 21, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) [...]
Exactus Appoints Emiliano Aloi as President
21/03/2019
DELRAY BEACH, Fla., March 21, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB:EXDI; OTCQB:EXDID ), a healthcare company pursuing opportunities in Hemp derived, Cannabidiol (CBD) products, announced it has appointed [...]
Bavarian Nordic Announces Annual Report 2018
21/03/2019
Copenhagen, March 21, 2019 (GLOBE NEWSWIRE) -- COPENHAGEN, Denmark, March 21, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its Annual Report for 2018. Below is a summary of business progress, [...]
New Board starts reviewing the situation in Oasmia
21/03/2019
March 19th, the Extra General Meeting in Oasmia elected a new Board on the initiative of the main owner Arwidsro. The EGM was well represented with over a hundred participating shareholders and over 400 proxies. Jörgen [...]
Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director
21/03/2019
LONDON, March 21, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Bavarian Nordic Awards Restricted Stock Units to Executive Management
21/03/2019
COPENHAGEN, Denmark, March 21, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company has awarded restricted stock units to members of the Executive Management. The Board of Directors of [...]

Pages